DM

Deerfield Management Portfolio holdings

AUM $6.52B
1-Year Est. Return 13.67%
This Quarter Est. Return
1 Year Est. Return
+13.67%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.01B
AUM Growth
+$259M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1 +$88.1M
2 +$62.8M
3 +$39.4M
4
LRMR icon
Larimar Therapeutics
LRMR
+$35.6M
5
PHAT icon
Phathom Pharmaceuticals
PHAT
+$26.8M

Top Sells

1 +$85.2M
2 +$69.6M
3 +$55M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$53.1M
5
DAWN icon
Day One Biopharmaceuticals
DAWN
+$49.7M

Sector Composition

1 Healthcare 53.67%
2 Financials 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
76
$2.96M 0.06%
732,543
-981,254
77
$2.87M 0.06%
455,262
78
$2.68M 0.05%
3,148,977
79
$2.33M 0.05%
2,651,667
+3,281
80
$1.55M 0.03%
486,068
-13,932
81
$1.26M 0.03%
672,000
82
$691K 0.01%
1,250,000
83
$649K 0.01%
16,733
84
$616K 0.01%
733,333
85
$550K 0.01%
+245,360
86
$390K 0.01%
1,000,000
87
$302K 0.01%
464,252
88
$177K ﹤0.01%
333,333
89
$53K ﹤0.01%
120,000
90
$45K ﹤0.01%
362,500
91
$33K ﹤0.01%
166,666
92
$31K ﹤0.01%
166,666
93
$20K ﹤0.01%
333,333
94
$13K ﹤0.01%
333,333
95
$10K ﹤0.01%
500,000
96
$9K ﹤0.01%
200,000
97
$7K ﹤0.01%
125,000
98
$7K ﹤0.01%
333,333
99
$7K ﹤0.01%
250,000
100
0